Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Mometasone vs Nasonex in Seasonal Allergic Rhinitis
NCT01038427Phase 3Completed
- Sponsor
- Sandoz
- Start
- Dec 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Sandoz. Started Dec 2009; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01038427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038427.